Harvard Health Blog

Stem-cell transplant: A possible high-risk/high-reward treatment for scleroderma

By: Robert Shmerling, MD, Faculty Editor, Harvard Health Publishing Some medical news stories donít get the attention they deserve. Perhaps itís because the disease is rare and not many people have ever heard of it. I think this story about a new treatment for scleroderma is a good example. Whatís scleroderma? …

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In